drugset / Trial / NCT02742233

Dipeptidyl Peptidase 4 Inhibition Facilitate Healing of Diabetic Ulcers

NCT02742233

Phase 4 Unknown 60 enrolled Long Min,MD
RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate the effect of Dipeptidyl Peptidase 4 Inhibition on wound healing in patients with diabetic foot ulcers, the investigators randomly divided the participants into two groups: saxagliptin with regular treatment group,placebo with regular treatment group. The clinical data are collected at the given time point. This study aimed to observe the potential protective effect of DPP4i on diabetic ulcers.

Timeline

Start
2015-11
Primary completion
2017-10
Completion
2017-11

Drugs

EvaluationDrugModalityDoseRoute
Subject SAXAGLIPTIN ANHYDROUS Small molecule 5 mg Oral

Indications